NCT01039987|Completed
Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease
CRISP II
Loading search results
CRISP II
Sponsor study identifier
observational
211
1 country
5
Study Start
September 1999
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2011
Actual (reported)Study Completion
March 2011
Actual (reported)The Division of Kidney Urology and Hematology Disease (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) funded a cooperative agreement (UO1) for a consortium of participating clinical centers (PCCs) and a data coordinating and imaging analysis center (DCIAC) to develop and implement studies to test whether imaging techniques can provide accurate and reproducible markers of progression of renal disease in patients with polycystic kidney disease. The awarded participating clinical centers are Emory University, University of Kansas, and Mayo Foundation (with a subcontract to the University of Alabama). The awarded DCIAC is Washington University in St. Louis. Due to the relocation of the DCIAC P.I. from Washington University to the University of Pittsburgh, the DCIAC for CRISP II is located at the University of Pittsburgh.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 2011
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 1999
Date type not reportedThis date has not been verified as actual or estimated.
December 23, 2009
Actual (reported)December 25, 2009
Actual (reported)March 2011
Actual (reported)March 2011
Actual (reported)kidney volume
three years
Participants who are diagnosed with ADPKD between the ages of 15 and 45 with risk factors (2/3 of the study population) or without risk factors (1/3 of the study population)for progression to ESRD with relatively normal renal function were be eligible for recruitment into the CRISP I study. The objective of the recruitment process was to identify ADPKD participants with the appropriate level of renal function who are either at high or low risk for progression to ESRD, who will be available for the entire follow-up period and who are likely to be compliant with the study protocols and visit schedules.
University of Alabama-Birmingham
Birmingham, Alabama, 35294, United States
Emory University
Atlanta, Georgia, 30322, United States
University of Kansas
Kansas City, Kansas, 66160, United States
Mayo Clinic
Rochester, Minnesota, 559005, United States
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
Bae K, Park B, Sun H, Wang J, Tao C, Chapman AB, Torres VE, Grantham JJ, Mrug M, Bennett WM, Flessner MF, Landsittel DP, Bae KT; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2013 Jul;8(7):1089-97. doi: 10.2215/CJN.10561012. Epub 2013 Mar 21.
blood, urine
Marva Moxey-Mims, M.D.
NIH, NIDDK, DKUH
K. Ty BAE, MD, PhD
University of Pittsburgh
211 participants (actual enrollment reported by the registry).
First Submitted
December 23, 2009
First Posted
December 25, 2009
Study Start
September 1999
Date type not reportedThis date has not been verified as actual or estimated.
Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Contact the study team to confirm eligibility.
Primary Completion
March 2011
Actual (reported)Study Completion
March 2011
Actual (reported)Last Updated
August 17, 2017
Record last verified: 2017-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: